<DOC>
	<DOCNO>NCT00455624</DOCNO>
	<brief_summary>The purpose study find androgen deprivation therapy affect insulin , cardiac risk factor cholesterol level , body fat muscle .</brief_summary>
	<brief_title>Prospective Study Insulin Resistance Cardiovascular Disease Risk During Androgen Deprivation Therapy Prostate Cancer</brief_title>
	<detailed_description>- This non-treatment study . This study effect care participant receive . - In addition participant routine standard medical appointment need make 2 additional outpatient visit special test 12 week . These 2 additional outpatient visit include follow : 1 ) urine blood test , 2 ) Oral Glucose Tolerance Test ( OGTT ) 3 ) Body measurement tape measure arm , leg , waist 4 ) x-ray evaluation ( CT scan bone density test ) .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Adenocarcinoma prostate , clinical stage M0 About initiate GnRH agonist therapy Karnofsky Performance Status 90 100 Serum creatinine &lt; 2.0mg/dl Hormone therapy within 12 month History diabetes mellitus glucose intolerance Anabolic agents metabolic agent know affect insulin glucose level Prior hormone therapy within past 12 month plan hormone therapy 12 week study ( Group 2 )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>androgen deprivation therapy</keyword>
	<keyword>insulin resistance</keyword>
</DOC>